주식/증권 📈 긍정적

Veracyte outlines 2027 view with ~10% volume growth and 22% adjusted EBITDA, while resetting Decipher prostate to 12,000-15,000 incremental tests

Seeking Alpha - Market News 11/06/2026 04:55:31 AM 2회

원문 기사 보기

관련 뉴스

Nephros GAAP EPS of $0.05 beats by $0.03, revenue of $5.6M beats by $0.11M

Enliven Therapeutics GAAP EPS of -$0.36

Tucows Non-GAAP EPS of -$0.52, revenue of $100M

Ultralife GAAP EPS of $0.14, revenue of $48.3M

뉴스 목록으로